Filing Details
- Accession Number:
- 0001127602-18-008948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-28 07:16:15
- Reporting Period:
- 2018-02-26
- Accepted Time:
- 2018-02-28 07:16:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Transaction Summary
| Sold: | 319 shares | Avg. Price: $108.53 | Total Value: $34,620.00 |
| Number of Shares After Transactions: | 14,078 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-26 | 100 | $108.50 | 14,515 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-26 | 119 | $108.50 | 14,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-26 | 100 | $108.59 | 14,296 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 218 | $108.95 | 14,078 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
